GMOV Fact Sheet: GMO U.S. Value ETF
Share
$32.17
close, Nov 18, 2026
Over the year to Nov 18, 2026, GMOV returned +25.1% in total and charged 0.50% a year.
- 1-year total return
- +25.1%
- to Nov 18, 2026
- Expense ratio
- 0.50%
- a year
- Net flow, 12 months to Aug 31, 2026
- +$36.9m
- monthly N-PORT basis to Aug 31, 2026
Growth of $10,000, 1 year
GMOV $12,513 +25.1% · PBUS $11,148 +11.5% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−1.5%
3 months−1.0%
Year to date+18.9%
1 year+25.1%
Since launch+34.7%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Microsoft Corp7.37%
Meta Platforms Inc5.35%
ExxonMobil Holdings Corp3.52%
Merck & Co Inc3.14%
Verizon Communications Inc2.54%
JPMorgan Chase & Co2.48%
Pfizer Inc2.41%
Bank of America Corp2.15%
Bristol-Myers Squibb Co2.06%
Johnson & Johnson2.01%
GMOV top ten by weight, 33.0% of the fund, of its 162 equity positions, from the holdings filed for Aug 31, 2026.
Facts
Equity fund · Actively managed · First traded Oct 29, 2024 · Benchmark Its own holdings, as of Aug 31, 2026